InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Mueller Brian, Chief Financial Officer. Director active across 1 company, notably Biomarin Pharmaceutical INC. Cumulatively, 29 disclosures have been published. Split: 0 buy · 7 sells. Total volume traded: €2m. History available since 30 April 2021. The latest transaction was disclosed on 17 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mueller Brian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
2,117 shares@ US$56.052.1% of flowCommon StockSEC:0001628280-26-019853:0
9,945 shares@ US$58.519.4% of flowCommon StockSEC:0001628280-26-019008:0
6,683 shares0Common StockSEC:0001628280-26-012529:0
18,497 shares@ US$69.4424.2% of flowCommon StockSEC:0001048477-25-000029:0
11,040 shares0Common StockSEC:0001048477-25-000019:0
588 shares@ US$82.330.9% of flowCommon StockSEC:0001048477-24-000120:0
300 shares@ US$68.6460.4% of flowCommon StockSEC:0001048477-24-000114:0
11,400 shares0Common StockSEC:0001048477-24-000044:0
4,602 shares@ US$88.937.7% of flowCommon StockSEC:0001048477-23-000023:0
9,630 shares0Common StockSEC:0001567619-23-005297:0
12,660 shares0Common StockSEC:0001209191-23-014617:0
2,500 shares@ US$63.103.0% of flowCommon StockSEC:0001567619-23-000965:0
2,500 shares@ US$114.505.4% of flowCommon StockSEC:0001567619-23-000965:1
2,500 shares@ US$63.103.1% of flowCommon StockSEC:0001567619-22-021667:0
1,101 shares@ US$104.502.2% of flowCommon StockSEC:0001567619-22-021363:0
2,139 shares@ US$67.812.8% of flowCommon StockSEC:0001567619-22-021363:1
2,139 shares@ US$104.504.3% of flowCommon StockSEC:0001567619-22-021363:2
3,761 shares@ US$67.815.0% of flowCommon StockSEC:0001567619-22-021363:3
3,761 shares@ US$104.507.6% of flowCommon StockSEC:0001567619-22-021363:4
934 shares@ US$95.091.8% of flowCommon StockSEC:0001567619-22-020937:0
3,500 shares@ US$67.814.7% of flowCommon StockSEC:0001567619-22-015384:0
3,500 shares@ US$94.506.6% of flowCommon StockSEC:0001567619-22-015384:1
7,337 shares@ US$89.5013.2% of flowCommon StockSEC:0001567619-22-013907:0
576 shares@ US$83.920.0004% mcap13.3% of flowCommon StockSEC:0001567619-22-013594:0
340 shares@ US$62.4070.0002% mcap5.8% of flowCommon StockSEC:0001567619-22-009717:0
25 of 29 declarations
About Mueller Brian
Mueller Brian is Executive Vice President and Chief Financial Officer at Biomarin Pharmaceutical INC, on the XNAS market. He has 29 filings in total, and within the recent filings tracked, the sell amount is EUR 2013044 between 2021-05-11 and 2026-03-19, with the dominant transaction nature shown as Attribution.
